<DOC>
	<DOCNO>NCT01793285</DOCNO>
	<brief_summary>Previous study suggest increase dos weekly etanercept 50 mg 100 mg improve efficacy treatment patient cutaneous psoriasis , rheumatoid arthritis , psoriatic arthritis . In line study , 2007 2008 period , conduct multicenter , double-blind , 12-week Study ( LoadET , 0881A3-102090 ) compare efficacy etanercept standard dose ( 50 mg/week ) versus double dose ( 100 mg/week ) subject AS refractory conventional therapy . The interim result say study appear support value double dose etanercept treatment subject AS . Once study finalise , subject continue monitored regular physician , decide dose treatment follow accord condition standard clinical practice . The objective observational study evaluate course disease long-term ( three year ) condition standard clinical practice , subject participate LoadET study . Therefore , would like follow-up patient review clinical history three-year period finalisation participation LoadET Study ( 0881A3-102090 ) . This allow u assess efficacy survival drug , well possible appearance side effect three year follow finalisation study compare result accord subject receive 50 mg/week 100 mg/week LoadET study ( 0881A3 102090 ) .</brief_summary>
	<brief_title>An Observational , Retrospective , Multicenter , National Study Monitoring Subjects Who Participated LoadET Clinical Trial</brief_title>
	<detailed_description>Given follow-up study subject participate LoadET study ( 0881A3-102090 ) , plan inclusion subject complete say study , , 97 108 subject LoadET study .</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>AS patient previously participate LoadET study ( 0881A3102090 ) . Subjects complete LoadET Study . Patients grant informed consent Patients participate LoadET study discontinue treatment , therefore , complete study . Patients without standard followup physician since end study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>